Overview

Entacapone Augmentation for Schizophrenia

Status:
Completed

Trial end date:
2006-10-01

Target enrollment:

Participant gender:

Summary

This study is testing the hypothesis that Entacapone added to ongoing antipsychotic treatment can be beneficial in schizophrenic patients with negative symptoms.

Phase:

N/A

Details

Lead Sponsor:

Rambam Health Care Campus

Treatments:

Entacapone